https://doi.org/10.4081/mem.2002.680
Il mifepristone
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Autori
Il contributo trae spunto dalla recente (ottobre 2002) autorizzazione da parte del Comitato Regionale del Piemonte alla sperimentazione del mifepristone - principio attivo della nota pillola abortiva RU486 - presso l'ospedale Sant'Anna di Torino e coglie l'occasione per ripercorrere, nella fase introduttiva, le tappe più significative della storia del mifepristone.
L'intento di questo studio, tuttavia, non è nè un'indagine storica, nè una valutazione delle effettive competenze di un Comitato Etico regionale ad autorizzare una sperimentazione, nè una comparazione tra aborto chirurgico e aborto medico, quanto piuttosto dare un'informazione documentata e attenta su aspetti spesso sottaciuti, ma importanti per conoscere a fondo questa moderna modalità di interruzione volontaria di una vita umana in sviluppo dentro il grembo della madre.
Vengono pertanto analizzati i dati disponibili in letteratura relativamente agli effetti collaterali, alle complicanze, ai rischi dell'aborto con uso di mifepristone/ misoprostolo e alle ricadute psicologiche per la donna. Vengono, inoltre, prese in esame le problematiche giuridiche del ricorso all'aborto medico ed analizzata l'applicabilità dell'articolo 9 della legge n. 194 del 1978 in materia di obiezione di coscienza.
Come citare
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.